mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.007 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.007 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.007 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.008 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.008 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.008 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.009 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.009 |